Physician

Arati S Desai, MD

According to 2025 Medicare claims, Arati Desai, MD (NPI: 1689638983) practices hospice and palliative care in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Chester, PA. This provider's primary affiliated billing organization is UNIVERSITY OF PENN-MEDICAL GROUP (NPI: 1679677975; TIN: 232743545) and primary practice location at 19104-5127.

Desai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 148 traditional Medicare patients, billed 392 HCPCS/CPT codes, and received $39,265 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 575 prescription claims across 109 beneficiaries totaling $170,058 in drug costs, led by Eliquis (Apixaban). DME data shows 113 claims. Open Payments data shows 4 records totaling $679. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $13,676 to $170,058. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $877 to $6,516.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	142	459	$40,601
2016	166	614	$50,923
2017	155	426	$36,171
2018	184	530	$45,288
2019	174	553	$49,448
2020	170	536	$43,964
2021	157	508	$50,666
2022	131	411	$40,062
2023	143	466	$46,376
2024	148	392	$39,265

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	42	186	$13,676
2016	60	327	$15,548
2017	71	344	$32,788
2018	91	443	$42,444
2019	107	679	$298,255
2020	106	642	$330,009
2021	81	416	$152,612
2022	86	432	$90,078
2023	103	583	$441,591
2024	109	575	$170,058

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	13	$612
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	38	58	$5,648
2020	40	90	$7,048
2021	26	77	$2,900
2022	46	116	$3,837
2023	47	110	$2,646
2024	52	113	$3,813

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	34	34	$145
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	79	204	$115
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	45	80	$75
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	12	27	$64

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	16	540	$10,394
Gleostine	Lomustine	11	390	$10,161
Lacosamide	Lacosamide	39	1,612	$8,026
Levetiracetam	Levetiracetam	121	6,080	$2,579
Dexamethasone	Dexamethasone	93	3,766	$2,094

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8700	Temozolomide, oral, 5 mg	N	21	57	$2,991
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	16	37	$464
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	15	19	$358

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$37	Novocure Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$642	Hospital Of The Univ Of Penna
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Arati S. Desai, MD?

Tedicare shows public-source Medicare data for Arati S. Desai, MD (NPI 1689638983), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Arati S. Desai, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Arati S. Desai, MD?

Arati S. Desai, MD is linked to UNIVERSITY OF PENN-MEDICAL GROUP (billing NPI 1679677975) in the available physician profile data.

Does Arati S. Desai, MD have Open Payments data?

Arati S. Desai, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.